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Background: Vibro-acoustography (VA) is a newly developed imaging technology that is based on low-frequency
vibrations induced in the object by the radiation force of ultrasound. VA is sensitive to the dynamic characteristics
of tissue. Here, we evaluate the performance of VA in identifying benign lesions and compare the results to those
of mammography.
Methods: An integrated mammography-VA system designed for in vivo breast imaging was tested on a group of female
volunteers, age≥ 18 years, with suspected breast lesions based on clinical examination. A set of VA scans was acquired
after each corresponding mammography. Most lesions were classified as benign based on their histological results.
However, in 4 cases, initial diagnosis based on clinical imaging determined that the lesions were cysts. These cysts were
aspirated with needle aspiration and disappeared completely under direct ultrasound visualization. Therefore, no biopsies
were performed on these cases and lesions were classified as benign based on clinical findings per clinical standards. To
define the VA characteristics of benign breast masses, we adopted the features that are normally attributed to such masses
in mammography. In a blinded assessment, three radiologists evaluated the VA images independently. The diagnostic
accuracy of VA for detection of benign lesions was assessed by comparing the reviewers’ evaluations with clinical data.
Results: Out of a total 29 benign lesions in the group, the reviewers were able to locate all lesions on VA images and
mammography, 100% with (95% confidence interval (CI): 88% to 100%). Two reviewers were also able to correctly
classify 83% (95% CI: 65% to 92%), and the third reviewer 86% (95% CI: 65% to 95%) of lesions, as benign on VA images
and 86% (95% CI: 69% to 95%) on mammography.
Conclusions: The results suggest that the mammographic characteristics of benign lesion may also be used to identify
such lesions in VA. Furthermore, the results show the ability of VA to detect benign breast abnormalities with a
performance comparable to mammography. Therefore, the VA technology has the potential to be utilized as a
complementary tool for breast imaging applications. Additional studies are needed to compare the capabilities of VA
and traditional ultrasound imaging.
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There are several different medical imaging modalities
for the screening and diagnosis of breast cancer [1-3].
However, benign breast lesions are much more common
than malignant lesions, and accurate diagnosis of these
lesions is important for optimal care of the patient [4].* Correspondence: Alizad.azra@mayo.edu
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unless otherwise stated.Benign breast disease (BBD) is a well-known, significant
risk factor for breast cancer [5]. BBD is diagnosed when
a woman has a breast biopsy for a palpable or imaging
abnormality in her breast that results in benign findings.
Any imaging evaluation of the breast with high sen-
sitivity may also be associated with increased false positive
results that may leads to unnecessary (i.e. benign) biopsies,
resulting in high cost as well as significant trauma and
anxiety for the patients due to this invasive procedure and
in some instances, they may choose unnecessary extensive
varieties of surgeries such as mastectomy [6,7]. Moreover,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tions such as cysts and fibroadenomas can reduce un-
wanted benign breast biopsies. It is, therefore, important
to develop imaging tools with higher specificity to reduce
false positive test results. Mammographic breast density
(MBD), another known factor, reduces the sensitivity of
mammograms [8]. Hence, there is an immense need for a
noninvasive tool that can assess breast tissue characteris-
tics while not influenced by MBD.
Conventional breast ultrasonography (US) is routinely
used as an adjunct imaging tool to x-ray mammography
for diagnosis of breast pathology; it improves sensitivity
and has a considerable role in differentiation of cysts and
solid nodules with higher specificity. US can also help to
characterize solid breast masses [3,9-14]. US features such
as lesion shape, orientation to the skin line, lesion bound-
ary, margin characteristics, echo-pattern, posterior acous-
tic appearance, and effects on the surrounding breast
tissue are employed to reach a Breast Imaging and Report-
ing Data System (BI-RADS) assessment [15]. In BI-RADS,
the lesions are categorized into 7 categories numbered 0
to 6. Categories 1 to 3 indicate being negative, benign
findings, or probably benign, respectively. Categories 4
and 5 are suspicious for malignancy, and 6 refers to having
known biopsy proven malignancy [15]. Abnormalities on
screening mammography that require further evaluation
are assessed as category 0; similarly, calcifications found
on breast US are also in category 0 assessment [16]. US is
usually used for the subsequent evaluation of BI-RADS
category 0 mammograms [17].
Benign breast lesions have a characteristic sonographic
appearance; cysts appear as well-circumscribed, round or
oval anechoic or hypoechoic masses with unnoticeable
walls and posterior acoustic enhancement [18]. Fibro-
adenomas typically appear as oval, well-circumscribed
masses with an abrupt interface and homogeneous iso- or
hypoechoic echo texture. Benign papilloma masses appear
as solid masses within a dilated duct with a vascular feed-
ing pedicle seen on color Doppler imaging [2,9,14]. There
is, however, an overlap between benign and malignant
lesion US characteristics leading to a significant number
of false-positive cases, which are recommended for US-
guided percutaneous biopsy [14]. An additional sono-
graphic tool to help decrease the number of unnecessary
biopsies can play an important role to reduce such a large
number of unnecessary biopsies. Imaging modalities, par-
ticularly those that provide palpation-like information, can
help to better diagnose and identify breast lesions.
Elasticity imaging is an emerging field of medical im-
aging that provides such information. Elasticity imaging
consists of magnetic resonance elastography (MRE) [23,24]
which is expensive and not widely available [19,20],
conventional quasi-static ultrasound elastography [21-23],
Acoustic Radiation Force Impulse (ARFI) imaging [24-26]and Shear Wave Elastography (SWE, also called SuperSonic
Imaging (SSI)) [27-31]. ARFI and SWE use ultrasound radi-
ation force to generate shear waves and quantify tissue
elasticity from measured propagation speed of shear waves
[32,33]. The results of studies using ARFI and SWE for
breast have been very promising.
Vibro-acoustography (VA) is an imaging modality that
also provides palpation-like information [34]. VA is intro-
duced as a complementary technique to improve sensitivity
and specificity in clinical breast imaging [35]. Principles of
VA have been described extensively [34,36-39]. In VA,
ultrasound is employed to produce a localized low-
frequency force to vibrate the tissue. In technical terms,
such a force is called “acoustic radiation force (ARF)”. The
low-frequency ARF is generated by two intersecting con-
tinuous wave (CW) focused ultrasound beams at slightly
different frequencies. This force, which acts as a point force,
vibrates the object at a frequency equal to the difference
between two US frequencies (typically in kHz range). The
resulting vibrations produce an acoustic emission field that
is detected by a sensitive microphone (or hydrophone).
Harder tissues normally produce a significantly different
acoustic emission compared to normal soft tissues. Concep-
tually, VA resembles palpation; i.e., detects tissue response
to an exerted force on tissue. [34,36]. However, VA benefits
from a significant advantage of using a highly localized ARF,
which leads to the possibility of assessing tissue properties
on a small scale. As a result, VA can provide detailed in-
formation on tissue mechanics at high resolution [38,39].
Compared to conventional US imaging, VA images are
speckle free, thus, the images have high-contrast that al-
lows detection of small structures [4,40,41]. Thus VA can
be a complementary tool to the existing breast imaging
tools. Compared to elastography techniques, VA uses
dynamic acoustic radiation force in the range of 10s of
kHz, which is much higher than the frequency used in
quasi-static elastography, ARFI, and shear wave imaging
(normally in 10s to 100s Hz range). VA mages represent
the acoustic response of tissue, which is a complex func-
tion of several parameters, including the elasticity and
viscosity. However, elasticity cannot be directly and quan-
titatively measured from this acoustic response.
Our preliminary studies demonstrated the abilities of VA
imaging in various tissues [40,42,43] including in vivo hu-
man breast [35,44]. In our previous studies [35,44], we used
a confocal VA system combined with mammography to
image various breast abnormalities, [35]. Since VA is a new
modality, characteristic of different types of lesions (benign
or malignant) in VA are not necessarily known. A goal of
this paper is to determine and present VA characteristics of
benign breast lesions. Another goal of this paper is to evalu-
ate the performance of such characteristics in identifying
benign lesions in VA and compare the results and compare
the results to those of mammography. To define the VA
Figure 1 Schematic of a VA system combined with mammography
illustrating the breast position. During mammography, the
transducer and hydrophone are transferred out of the x-ray path. A
compression panel is covered with a latex membrane with the size of
80 × 80 mm acoustic window. The imaging area within the acoustic
window is 50 × 50 mm.
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tures that are normally attributed to such masses in mam-
mography. Such features, which are often defined in
contrast to those of malignant masses, include morpho-
logical attributes of the mass and information related to cal-
cifications. We will test the validity and performance of
these characteristics in a reader-based study.
Methods and materials
Study subjects
Under an approved protocol by the Mayo Clinic Institu-
tional Review Board (IRB), female volunteers (18 and
up) were chosen for the study and informed consent was
obtained from all enrolled patients. Pregnant women
were excluded from this study. We selected 36 patients
with benign lesions based on pathology and clinical data.
Five of the 36 patients examined were used for training
and excluded from the study. Also, two participants were
excluded from the study because of accidental hardware
failure that occurred during the study. In the group of 29
women with benign lesions, 25 underwent ultrasound-
guided core needle biopsy. The other 4 cases, based on
radiologist impression of mammography and/or breast
ultrasound, diagnosis of simple cyst was made and the
cysts were aspirated and disappeared completely under
direct ultrasound visualization, therefore, no histology was
necessary for these 4 cystic lesions.
VA system
An experimental mammography-VA system, designed for
in vivo breast imaging [35], was used to image patients
with benign breast lesions. The VA system was integrated
into a clinical stereotactic mammography machine (Mam-
moTest system; Fischer Imaging, Inc, Denver, Colorado,
USA) so that we could have matching VA and mammog-
raphy images (from the same view angle) for comparison.
Figure 1 represents the diagram of this system. It should
be noted that VA is a noninvasive imaging tool, and it has
been shown that VA can function at ultrasound intensities
within the FDA limits. VA System parameters are: trans-
ducer frequency = 3 MHz, transverse resolution = 0.7 mm,
scanning increments = 0.2mm, ultrasound intensity at
the focal point = 700 mW/cm2 in compliance with the
FDA recommendation for in vivo diagnostic ultrasound
[45]. The thermal safety of VA system is discussed in
detail in [46].
The patient rested on an examination bed in a prone
position. Through a hole in the bed, the breast was po-
sitioned between the back panel, including an x-ray de-
tector, and a sliding panel that slightly compresses the
breast. The compression was constant and at minimal
level during VA acquisitions. A thin latex membrane
covers the window of the compression panel that is
transparent to the US beams, and the US transducer islocated behind the window. All VA images were ac-
quired in the cranial-caudal view at various depths from
the skin. The VA images were acquired by mechanically
scanning the confocal VA probe, and each scan covered
a 50 × 50 mm area with a scan step size of 200 μm in
each direction. VA image resolution is determined by
the spatial resolution of the mixed US beams (i.e. low
frequency ARF) and was about 700 μm [34,47]. A hydro-
phone (Bruel & Kjaer model 8106) was placed on the side
of the breast to receive the acoustic emission generated by
the radiation force of US. Upon finishing a mammography
scan, a set of VA scans at different depths was acquired
by adjusting the distance between the confocal VA probe
and breast tissue.
Reference standard documentation
After mammography, a set of VA scans was acquired by
the experimental device. Then we selected the group of
patients with benign lesions based on pathology, and in
some cases, based on clinical findings and radiologist
impression. To characterize the benign lesions’ morpho-
logy, we reviewed all data including the corresponding
X-ray mammograms acquired during the VA testing,
other available clinical images such as clinical mammo-
grams, US, and clinical data such as palpation informa-
tion from the patient record. Based on these data, the
shape and location of the benign lesion in the VA im-
aging window were determined.
Criteria for benign and malignant masses
Findings such as irregular or oval shaped; indistinct or
ill-defined borders, presence of architectural distortion
and or spiculations, presence of clustered pleomorphic
microcalcifications are common characteristics of malig-
nant breast masses. Round punctate calcifications are
mostly benign unless appears as a segmental or linear
distribution would be at least suspicious [48]. Other
Figure 3 VA and mammography images of Case 1. (A) Prone
cranial-caudal mammogram of the right breast shows a mass. (B)
and (C) are VA images at 50 and 20 KHz frequencies, respectively, at
a depth of 25 mm. The structural details are more pronounced at 50
kHz. The arrows mark the location of the mass. The slight upward
shift was due to patient movement after mammography.
Figure 2 Flow chart indicating the result of VA image review
by three radiologists aiming on identification of benign
abnormalities. (MMG =mammography, Rev = Reviewer).
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round shape and lobulated masses, or simple cysts with
soft wall are characteristics of benign lesions. However,
intra cystic mass, masses with eccentric cystic spaces or
thick wall cysts with thick separation are usually malig-
nant [18].
Reader interpretation
VA images were evaluated independently by three inde-
pendent reviewers (radiology residents) who identified
breast lesions and location. Because the reviewers did
not have prior experience with VA imaging interpret-
ation, they underwent a training session to learn about
VA images and familiarize themselves with the general
appearance of normal breast tissues. Masses and calcifi-
cation in a typical VA image and five images used for
training were excluded from the study. For training pur-
poses, all the clinical data were given to the reviewers.
However, for the remaining test set, we asked reviewers
to locate and identify the benign lesion without having
access to any clinical data. The reviewer evaluated each
lesion based on the criteria for the benign masses in-
cluding size, shape, margins, presence of microcalcifi-
cations, and presence of architectural distortion and/or
spiculations, and determined if lesion was benign or not.
In a separate session, the reviewers evaluated only the
mammography images based on similar criteria.
Statistical considerations
Observer performance for detection of a breast lesion
and correct classification of the lesion was measured
using proportions and score confidence intervals.
Results
Women volunteers with abnormality in their clinical
breast examination and/or mammography BI-RADS cat-
egory 4 or less were included in this study. All patients
underwent clinical mammography and breast US before
participation in the study. VA imaging was done on all
subjects. In total, 36 patients with benign lesions were
evaluated; five were used for training and excluded from
the evaluation. Also, two participants were excluded from
the study because of accidental hardware failure that oc-
curred during the study. A total of 29 patients, averaging
44 years old, with benign lesions were evaluated. The final
diagnosis for 25 patients was based on histological results.
In the remaining 4 patients, based on clinical imaging, the
lesions were determined to be simple cysts. These cysts
were aspirated with needle aspiration and disappeared
completely under direct ultrasound visualization. There-
fore, the final diagnosis includes six benign cysts, 15 fibro-
adenomas, three papillomas, and three of post-surgical
scar tissue, and two focal atypical ductal hyper-
plasia with microcalcifications. The flow chart shownin Figure 2 demonstrates the results of VA image eva-
luation by three independent readers’ reviews in 29 pa-
tients with benign lesions and their final diagnosis. The
lesion detection rate for each radiologist was 100% with
(95% confidence interval (CI): 88% to 100%). While all
29 lesions were confirmed to be benign (25 biopsy
proven and 4 cysts with aspiration), the primary clinical
imaging review of reference image (mammography)
indicated that four lesions were suspicious for malig-
nancy, therefore, the correct classification as benign
was 86% (95% CI: 69% to 95%). This uncertainty was
also observed using the new imaging modality. Correct
classification as benign by the reviewers was either 83%
(95% CI: 65% to 92%) or 86% (95% CI: 69% to 95%) as
shown in Figure 2. Readers 1 and 2 misclassified three
of the lesions as suspicious and two as malignant.
Reader 3 misclassified three of the lesions as suspicious
Figure 4 VA, US and mammography images of Case 2. (A) Prone cranial caudal mammogram image corresponding to the VA image
showing only a marker placed in the vicinity of a palpable mass. (B) US of same breast shows a hypoechoic lobulated mass. (C and D) VA
images of the same breast at 60 kHz and at 20 mm and 25 mm depths, respectively. Arrows mark the location of the breast mass.
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cussed in the following section.Review of select cases
To further demonstrate the abilities of VA in detecting
breast benign lesions, we present VA images of eight
identified cases and compare VA results with that of
conventional US and mammography. We also present
three of the cases that were misclassified in mammo-
graphy as well as VA images.Cases of fibroadenomas identified by both mammography
and VA
Case 1 The patient was a woman in her 70s. Her
screening mammography showed scattered fibroglan-
dular densities in both breasts and a mass lesion in her
right breast (fibroadenoma). The prone cranial-caudal
mammogram of the right breast showed a 2 cm, sharply
marginated mass with coarse lobulations of a soft-tissue
mass (Figure 3A). The fibroadenoma region was clearly
seen in the VA images, taken at a depth of 25 mm below
the skin (Figure 3B and C), denoted by arrows. The VA
images could show the gentle coarse lobulation in the
mass, a classic finding in fibroadenoma, and the margin
very well. The mammogram additionally showed a well-
circumscribed 3 mm calcification near the mass, but it
was out of focus in the VA image, due to its different
depth (Figure 3). This case demonstrates that VA can
identify fibroadenomas.Figure 5 VA, US and mammography images of Case 3. (A) Mammogra
marked by our radiologist. (B) US image of left breast shows a hypoechoic
marked by our radiologist.Cases of fibroadenomas not seen on mammography but
identified on VA
Case 2 The patient, a woman in her 40s, presented with
a palpable mass in the right breast. Targeted US showed
a 29 × 19 × 13 mm well-defined lobulated and mildly
hypoechoic mass. Her diagnostic mammography showed
heterogeneous dense parenchyma in both breasts, but
was not able to detect the palpable mass on right breast.
A marker was placed on the skin to identify the appro-
ximate location of palpable mass as seen in the ultra-
sound (Figure 4A and B). The VA images indicated a
round mass with a defined border and some lobulation
inside denoted by arrows (Figure 4C and D). The patho-
logy result revealed the mass to be a fibroadenoma. This
case demonstrates that VA can identify mass lesions not
seen on mammograms.
Case 3 The patient, in her 30s, presented with a palp-
able lesion in the left breast. Her mammography showed
an extremely dense breast, and there is no discrete
mammographic abnormality in the area of the palpable
abnormality because of the highly dense tissue. The US
image showed a benign appearing hypoechoic mass in
the left breast. The VA image reveals a lobulated mass
with a defined border (Figure 5). This case demonstrates
that VA can identify mass lesions (in this case a biopsy
proven fibroadenoma) not seen on mammograms.
Case 4 (Benign Papilloma) The patient was in her 50s.
Her mammography demonstrated scattered fibroglandularphy does not show any discrete abnormality, the lesion location
mass. (C) VA image shows a lobulated mass in an area of concern
Figure 6 VA, US and mammography images of Case 4. (A) X-ray mammogram of the left breast, which corresponds to the same view as VA
showing a small nodular density. (B) US of left breast shows 1 cm elongated solid circumscribed nodule. (C) VA image at a 30 mm depth shows
the elongated solid nodule at the same location of X-ray.
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suring about 10 mm in her left breast. Clinical US revealed
a 10 mm elongated solid circumscribed nodule. VA im-
ages acquired at a 30 mm depth showed the same elon-
gated nodule at the same location as that shown in X-ray
(Figure 6). The result of pathology classified the lesion as
a papilloma with stromal fibrosis. This case demonstrates
the ability of VA in identifying a benign papilloma.
Cases of benign cysts
Case 5 The patient, in her 50s, presented with a palp-
able mass in the left breast. Her mammography demon-
strated scattered fibroglandular densities (D2) in both
breasts and a circumscribed lobulated mass measuring
about 2 cm in the left breast. Targeted US indicated a
benign cyst in the area comparable to mammography.
VA images at a different depth (Figure 7) showed a well-
defined mass about the same size and location seen in
the mammogram (denoted by arrows). The patient was
diagnosed with a benign cyst and the fluid was com-
pletely drained under guided US. This case demonstrates
that VA can identify benign cystic lesions.
Case 6 The patient, in her 40s, presented with an oil
cyst in the right breast near the nipple. Mammography
demonstrated scattered fibroglandular tissue and a
20 mm radiolucent well-defined mass with soft border,
which was consistent with an oil cyst, along with several
calcifications near the larger cyst. Clinical US revealed
the presence of the cyst as a hypoechoic mass. VA im-
ages acquired at 20, 25, and 30 mm depths (Figure 8)
confirmed the presence of a well-defined circumscribedFigure 7 VA, US and mammography images of Case 5. (A) Mammogra
showing a hypoechoic mass. (C) and (D) are VA images at depths of 30 m
same location as the mammogram (denoted by arrows).mass with soft border. This case demonstrates that VA
can identify a benign oil cyst.Misidentified cases
Case 7 The patient, in her 50s, presented with a previous
lumpectomy site above the left nipple. The patient was ini-
tially scheduled for a screening mammography, but a ques-
tionable new abnormality on the left breast necessitated
additional imaging evaluation. Diagnostic mammogram
demonstrated scattered fibroglandular densities in both
breasts, and architectural distortion in a predominately ra-
dial pattern that could be due to resection of an invasive
carcinoma approximately 5 years earlier or recurrence of
cancer. VA images showed the area of concern as a spicu-
lated or radial pattern architectural distortion (Figure 9).
Final assessment was benign post-operative changes.
We had three cases of post-surgical scar tissue that
imitated spiculation, the hallmark of a cancerous lesion;
one shown in Figure 9. These cases were misidentified
as malignant in both mammography and VA because of
the misleading radial pattern distortion due to post-
surgical scar tissue.Case 8 The patient was in her early 50s. Her mam-
mography shows extremely dense breasts. Diagnostic
mammography demonstrated indeterminate calcifications,
clustered and scattered, in the left breast. VA was also able
to reveal this cluster of microcalcifications and ductal cal-
cifications. Biopsy presented focal atypical ductal hyper-
plasia (ADH) with associated calcifications (Figure 10).
This patient had an extremely dense breast and due tom showing a 20 mm circumscribed lobulated mass. (B) Targeted US
m and 35 mm, respectively. A mass with soft border is observed at the
Figure 8 VA, US and mammography images of Case 6. (A) Mammogram taken corresponding to the VA view showing a 20 mm well-
circumscribed lesion with soft border and several calcifications near the lesion. (B) Targeted US showing a hypoechoic mass confirmed as an oil
cyst. (C and D) are VA images at 25 mm and 30 mm depths, respectively. The well-defined mass with soft border is seen in all VA images. Note:
breast repositioned in (D) and cyst seen in center of the image.
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misidentified this case as malignant.
Discussion
The goal of this study was to primarily investigate the
diagnostic accuracy of VA in detecting benign breast le-
sions. Various types of benign breast lesions including
lipid cyst, benign cyst, benign fibroadenoma, and benign
papilloma were studied with a laboratory-built VA system
integrated with a mammography machine. The results of
the study clearly show the efficacy of VA in detecting be-
nign breast lesions. Also, the results show that the mam-
mographic attributes of benign lesions can be adopted to
identify such lesions in VA imaging.
We explored the VA characteristics of a wide range of be-
nign lesions. Regular shape, well-defined lesion boundary,
distinct or soft margin, and soft lobulation are the most be-
nign characteristics we found on VA images. Cysts ap-
peared on VA images as well-defined masses with a soft
border as seen in Figures 7 and 8 and all reviewers could
identify all cyst cases. Fibroadenomas, the most common
solid breast masses that undergo breast biopsy, appeared
on VA images as well-circumscribed ovoid or round massesFigure 9 VA and mammography images of Case 7. (A) X-ray
mammogram of left breast which corresponds to the same view as
VA showing a radial pattern architectural distortion with surgical
clips. (B) VA image at 20 mm depth showing the same speculated-
like architectural distortion denoted by the circle. Parts of surgical
clips can also be seen in the VA images.with gentle lobulation, and in some cases were calcified as
seen in US and mammography, which happens in degener-
ating fibroadenomas [49,50].
Three cases of fibroadenomas and one case of papil-
loma that were unidentifiable by mammography were
marked by our radiologist and detected by VA. Similarly
seen in breast US [14], VA can help identify lesions that
are obscured in mammography due to dense breast. VA
also identified benign papilloma lesions as elongated
nodules in a dilated duct; one papilloma was not iden-
tifiable on mammography but seen using VA. Diagnosis
of papilloma is important and surgical excision should
be considered for core needle biopsy proven benign
papilloma - especially for lesions larger than 1.5 cm,
regardless of imaging findings [41]. As expected, VA
worked better than mammography in dense breast.
The cases that were misclassified by VA were also mis-
identified by mammography. Three of the misidentified
cases were post-surgical scar tissue, as shown in Figure 9,
presenting as a radial pattern distortion imitating spicu-
lation, which is most seen in malignant tissue. It should
be noted that mammographically only some of these
changes can be differentiated based on morphological
characteristics. Even though microcalcifications are often
associated with breast carcinoma, not all spiculated le-
sions including microcalcifications are considered ma-
lignant. Mammography alone is often not a reliable
imaging tool for making the definitive diagnosis in these
cases. Additional mammographic views, breast US, cli-
nical breast examination, and needle or surgical biopsy
are often required [18].
Two other misclassifications occurred in focal atypical
ductal hyperplasia (ADH) with associated calcifications
as shown in Figure 10. The presence of a cluster of in-
determinate microcalcifications is always suspicious of
ADH or ductal carcinoma in situ (DCIS). ADH is a le-
sion with significant malignant potential. The diagnosis
of ADH at needle core breast biopsy is normally con-
sidered as an indication for surgical excision [19,21,46].
In these two cases, VA and mammography were in
agreement on suspicious lesions.
Figure 10 VA and mammography images of Case 8. (A) A cluster of calcifications and some scattered microcalcifications, which can be better
seen in the magnified images of the square box part of x-ray shown in (B). (C) VA image of the breast at 1 cm depth and normal sum of frequencies.
The cluster of microcalcifications and ductal calcification are visible. Note: Due to patient’s repositioning during the experiment, calcifications are seen
on the far right of the VA image.
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are simply reconstructed from the amplitude of the
acoustic emission; additional signal and image pro-
cessing algorithms were not required. The resolution
of the VA images is determined by the spatial distri-
bution of the ARF and is in the sub-millimeter range.
Such resolution is generally sufficient for detecting
the breast lesions. Since VA and US share common
hardware (US scanner and transducer), we envision
that in the future VA can be combined with conven-
tional US imaging and become a hybrid imaging
modality that can provide physicians with further
clinically useful information.
We used mammography as the reference modality be-
cause the confocal VA system is integrated with a mam-
mography machine that allowed acquiring matching
mammography and VA images from the same view
angle and through the same imaging window, which fa-
cilitated the comparison. We also note that traditional
breast US and elastography images are obtained in the
B-Plane, which is perpendicular to the C-plane images
of VA. This difference in imaging plane makes it difficult
to compare VA against US and elastography images to
match the location of breast lesions. In contrast, we can
obtain VA and mammography from an identical imaging
window, thus one-to-one comparison becomes possible.
We also emphasize that VA is introduced as a comple-
mentary technique to improve sensitivity and specificity
in clinical breast imaging [35]. Compared to conven-
tional US imaging, VA images are speckle free, thus, the
images have high-contrast that allows detection of small
structures such as microcalcifications. Thus VA can be a
complementary tool to the existing breast imaging tools.
Compared to elastography techniques such as ARFI [32]
and SWI [33], VA uses dynamic acoustic radiation force
in the range of 10s of kHz [34], which is much higher
than the frequency used in quasi-static elastography,
ARFI, and shear wave imaging (normally in 10s to 100s
Hz range). VA images represent the acoustic response of
tissue, which is a complex function of severalparameters, including the elasticity and viscosity. How-
ever, elasticity cannot be directly and quantitatively mea-
sured from this acoustic response.
VA imaging of the breast with a confocal VA system in
the prone position has certain limitations. One of the
drawbacks of this system is limited access to parts of the
breast near the chest wall. This was due to mechanical
limitations caused by the patient position (prone pos-
ition) which put a part of the breast close to the chest
wall outside the imaging window and thus not access-
ible. Also, the need for two-dimensional raster scanning
of the transducer resulted in slow image acquisition. To
overcome such limitations of confocal VA, we recently
developed a new VA system with a handheld array trans-
ducer that is implemented on a clinical ultrasound scan-
ner. This system is now being tested in an ongoing study
on patients in supine position [51].
We understand that malignant lesions are clinically
more important. We decided to focus this study on be-
nign breast lesions, because benign lesions are also cli-
nically important as they are much more common than
malignant breast lesions. Benign breast lesions cover a
wide range of abnormalities with different VA character-
istic, thus warranting a separate a study.
Furthermore, the case selection did not represent a
typical screening process. Nonetheless, this study repre-
sented an important first step in studying the utility of
VA for detection and characterization of breast masses.
Despite the mentioned limitations, the results of this
study show the ability of the technique to identify the
benign lesions with high clarity and present VA charac-
teristics of a wide range of benign lesions.
Although the sample size in the present study was ra-
ther small, we believe that our results can be reproduced
and validated in future clinical studies. We anticipate
that by implementing VA on a clinical US scanner and
by using a 2D US transducer [52], VA will become a
more suitable tool for clinical usage. Additional studies
are needed to compare the capabilities of VA and tra-
ditional ultrasound imaging.
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